Delivering value through Insights that matter!

Home / Report / Healthcare / Diagnostics / Global Predictive Presymptomatic Testing Market

Global Predictive Presymptomatic Testing Market

$3,850.0 – $7,700.0

Industry Analysis, Forecasts and Opportunity Assessment (2017-2022)

  • Market Trends, Dynamics and Regulatory Framework
  • Regional and Cross-segment Sales Figures
  • Extensive Industry Structure Coverage

Sample Report Request Customisation

Clear
SKU: N/A Category:

Description

Predictive presymptomatic testing is the genetic testing used to detect gene mutations linked with disorders that appear at birth. These tests are useful for people and families who have genetic disorders but no apparent features of the disorder. These predictive testings help in identifying the mutations that could develop into disorders on a genetic basis. This is applicable for certain types of cancer, hemochromatosis, Down’s syndrome etc. They can predict whether a person will develop a particular disease much before symptoms appear and can therefore help in precaution and early treatment.

Market Dynamics

The global market for Predictive presymptomatic testing is on the rise due to the prevalence of chronic, fatal, infectious genetic diseases that have no proper cure or are painful. This has increased the demand for personalized medicines and has encouraged legislative and regulatory policies. Also due to advancement in science and technology predictive testing has become an important market in healthcare. There are a various government initiatives being taken to spread awareness about such testing. The global genetic testing market is said to grow at a CAGR of around X% over the next decade to reach a figure of X% in the year 20XX.

Market Segmentation

The Global Predictive Presymotomatic Testing market can be divided on the basis of diseases such as thalassemia, sickle cell anemia, alzheimer’s disease, Huntington’s disease and so on. Technologically the market can be divided into molecular testing, cytogenic testing and biochemical testing. The application of such predictive testing are in the fields of cancer genetic testing, prenatal genetic testing, filling and capping machinery, pharmacogenomics testing and predisposition cancer genetic testing. North America is the highest grossing market in predictive presymptomatic testings due to their well established health-care sector, high awareness level and adoption of new technologies. They are followed by Europe. However, the growth in Asia Pacific is anticipated to be the most due to large population, increase in disposable income etc. India and China are favourable growing markets for predictive testing.

Key Players

23andMe, Inc., Abbott Molecular, Bayer HealthCare AG, Biocartis SA, BioHelix Corporation, BioMerieux S.A., Celera Corporation, Cepheid, Daan Diagnostics Ltd., EKF Diagnostics Holdings plc are major key players in Global Predictive Presymptomatic Testing Market

The report contains comprehensive analysis on:

• Global Predictive Presymptomatic Testing Market Segments

• Global Predictive Presymptomatic Testing Market Drivers, Restraints and Opportunities

• Global Predictive Presymptomatic Testing Market Size & Forecast 2016 to 2022

• Supply & Demand Value Chain

• Global Predictive Presymptomatic Testing Market Current Trends

• Competition &Major Companies

• Technology and R&D Status

• Porters Five Force Analysis

• Strategic and Critical Success Factor Analysis of Key Players

Regional analysis for Feed Software Market includes
Industry Analysis, Forecasts and Opportunity Assessment (2017-2022)

  • Market Trends, Dynamics and Regulatory Framework
  • Regional and Cross-segment Sales Figures
  • Extensive Industry Structure Coverage
Sample Report Request Customisation

Related Products:

Global Predictive Presymptomatic Testing Market

The Global Genetic Testing Market was valued at US$ XX billion in 2016 and is expected to grow at around XX% CAGR to reach nearly US$ XX billion by 2022. Genetic testing is a form of medical testing in which the genes and chromosomes are examined in order to diagnose a medical condition or predict the probability of occurrence of a disease. Genetic testing is also used in other areas like forensic investigation and determination of physiological characteristics of foetuses. Growing incidence ...

Global Predictive Presymptomatic Testing Market

In-vitro Toxicology Testing is the scientific analysis of the effects of toxic chemical substances on mammalian cells or cultured bacteria. In vitro (which means in glass) testing methods are used mainly to identify potentially harmful chemicals and/or to confirm the dearth of certain toxic properties in the early stages of the development of potentially useful new products such as agricultural chemicals, therapeutic drugs, and food additives. The In-vitro Toxicology Testing Market was valued...

Global Predictive Presymptomatic Testing Market

The global microbiology testing market is projected to reach USD X bn in 2022, up from about USD X bn in 2017, growing at a CAGR of X% during the forecast period 2017-2022. The growth of the microbiology testing market has been attributed to epidemic outbreaks, increased infectious disease cases, and a shot in the arm for life science research through funding and investments. The Asia-Pacific regions are expected to surpass their counterparts and current powerhouses in the market, Europe and ...

Global Predictive Presymptomatic Testing Market

Newborn screening testing is the practice of testing newborn children for certain fatal diseases that are not evident at birth. It was started by scientist Robert Guthrie in 1960s when he developed a test to check for the metabolic disorder called phenylketonuria. A simple blood test is conducted after birth which reveals the conditions that could eventually develop into chronic illnesses. Diseases diagnosed in the newborn screening test are phenylketonuria,congenital hypothyroidism, galactos...

Global Predictive Presymptomatic Testing Market

The Global Autoimmune Disease Diagnostics Market was valued at US$ XX billion in 2016 and is expected to grow at around XX% CAGR to reach nearly US$ XX billion by 2022. Autoimmune diseases are diseases in which the patient’s immune system starts attacking the normal and healthy cells of the patient. The autoimmune disease diagnostics market consists of devices and procedures that help to diagnose whether the patient is suffering from an autoimmune disease and also the type of the autoimmune d...

Global Predictive Presymptomatic Testing Market

The Global Cancer Biomarkers Market is valued at USD XX Billion in 2016 and is poised to reach USD XX Billion by 2022 growing at a CAGR of XX% during the forecast period. Biomarkers are chemical, physical or biological parameters used for cancer detection. They are produced by either the cancerous cell or by some other cell in response to cancer. They form one of the most non-invasive and high-speed cancer detection techniques. Biomarkers facilitate a plethora of applications such as cancer d...

Global Predictive Presymptomatic Testing Market

The Global Colorectal Cancer Screening Market is valued at USD XX Billion in 2016 and is poised to reach USD XX Billion by 2022 growing at a CAGR of XX% during the forecast period. Cancer occurs due to the uncontrolled growth of certain type of cells in the body. If untreated, this abnormality can spread to other areas of the body. Colorectal cancer is the third most commonly diagnosed cancer and the third leading cause of cancer death in both men and women in the US. The symptoms of colorect...

Global Predictive Presymptomatic Testing Market

Introduction Crohns disease is a chronic inflammatory disease that can affect any part of the gastrointestinal tract from mouth to anus. The disease can cause significant lifestyle sacrifices and suffering and millions of dollars are spent in related health-care cost every year. The diagnosis of Crohns disease is mainly done through a combination of tests like Tests for anemia or infection and Fecal occult blood test. Currently, there is no cure available for Crohns disease, and there is n...

Global Predictive Presymptomatic Testing Market

The Global Diagnostic Imaging Market is valued at USD XX Billion in 2016 and is poised to reach USD XX Billion by 2022 growing at a CAGR of XX% during the forecast period. Medical imaging is a prerequisite in most of the treatments as a means to examine patients and establish their exact medical condition. With the increasing awareness on preventive care, people undergo medical check-ups more often than earlier which has resulted in such imaging techniques gaining significance. The diagnostic...

Global Predictive Presymptomatic Testing Market

Introduction Head and Neck cancers can be called as the various types of malignant tumors grown in and around head and neck and are one of the most deadly type of cancers in the world. They initiate in squamous cells that line the mucosal surface of head and neck and are called as squamous cell carcinoma. The symptoms for these cancers include headache, common cold, change in voice, soreness in the mouth, and swelling of jaws. They are among the ten most common types of cancers worldwid...

Global Predictive Presymptomatic Testing Market

The occurrence of kidney cancer has increased in the recent years. Excessive smoking, rise in obesity because of sedentary life routines and increased consumption of alcohol are some of the causes of kidney cancer. The most common type of cancer is Renal Cell Carcinoma (RCC), also known as renal cell cancer or renal cell adenocarcinoma. Almost 9 out of 10 kidney cancers are renal cell carcinomas. Another type of kidney cancer present among a few individuals is transitional cell carcinoma (TCC...

Global Predictive Presymptomatic Testing Market

Introduction Mammography is known as the process of using low-radiation X-rays to diagnose tumours in the human breast. Mammography equipment (mammogram) is fundamentally used as a diagnostic and screening tool. The main purpose of mammography is the early detection of breast cancer through the identification of microcalcifications (tiny specks of calcium deposits that can be scattered throughout the mammary gland). Mammography is believed to reduce mortality from breast cancer by early de...

Related products

×
Sample Report
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. You may contact us at any time to opt-out. Please tick here to receive these communications.
×
Report Customisation
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. You may contact us at any time to opt-out. Please tick here to receive these communications.
×
Services Contact
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. You may contact us at any time to opt-out. Please tick here to receive these communications.
×